Patents by Inventor Jacques Wepierre

Jacques Wepierre has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Prevention and treatment of breast cancer with 4-hydroxy tamoxifen
    Patent number: 8475814
    Abstract: Pharmaceutical compositions of 4-hydroxy tamoxifen, particularly compositions suitable for percutaneous administration, are useful in methods for treating and preventing breast cancer. When percutaneously administered to a patient's breasts, 4-hydroxy tamoxifen concentrates locally, and exerts an anti-estrogenic effect. In patients with breast cancer, this effect reduces tumor tissue proliferation. In patients at risk for developing breast cancer, the anti-estrogenic effect prevents breast tumor formation.
    Type: Grant
    Filed: January 14, 2009
    Date of Patent: July 2, 2013
    Assignee: Besins Healthcare Luxembourg SARL
    Inventors: Philippe Rouanet, Dominique Salin Drouin, Jacques Wepierre
  • Percutaneous composition comprising 4-hydroxy tamoxifen
    Patent number: 7704516
    Abstract: Pharmaceutical compositions of 4-hydroxy tamoxifen, particularly compositions suitable for percutaneous administration, are useful in methods for treating and preventing breast cancer. When percutaneously administered to a patient's breasts, 4-hydroxy tamoxifen concentrates locally, and exerts an anti-estrogenic effect. In patients with breast cancer, this effect reduces tumor tissue proliferation. In patients at risk for developing breast cancer, the anti-estrogenic effect prevents breast tumor formation.
    Type: Grant
    Filed: December 15, 2003
    Date of Patent: April 27, 2010
    Assignee: Laboratories Besins International SA
    Inventors: Dominique Salin Drouin, Jacques Wepierre
  • PREVENTION AND TREATMENT OF BREAST CANCER WITH 4-HYDROXY TAMOXIFEN
    Publication number: 20090186944
    Abstract: Pharmaceutical compositions of 4-hydroxy tamoxifen, particularly compositions suitable for percutaneous administration, are useful in methods for treating and preventing breast cancer. When percutaneously administered to a patient's breasts, 4-hydroxy tamoxifen concentrates locally, and exerts an anti-estrogenic effect. In patients with breast cancer, this effect reduces tumor tissue proliferation. In patients at risk for developing breast cancer, the anti-estrogenic effect prevents breast tumor formation.
    Type: Application
    Filed: January 14, 2009
    Publication date: July 23, 2009
    Inventors: Philippe ROUANET, Dominique Salin Drouin, Jacques Wepierre
  • Prevention and treatment of breast cancer with 4-hydroxy tamoxifen
    Publication number: 20050031695
    Abstract: Pharmaceutical compositions of 4-hydroxy tamoxifen, particularly compositions suitable for percutaneous administration, are useful in methods for treating and preventing breast cancer. When percutaneously administered to a patient's breasts, 4-hydroxy tamoxifen concentrates locally, and exerts an anti-estrogenic effect. In patients with breast cancer, this effect reduces tumor tissue proliferation. In patients at risk for developing breast cancer, the anti-estrogenic effect prevents breast tumor formation.
    Type: Application
    Filed: December 15, 2003
    Publication date: February 10, 2005
    Inventors: Philippe Rouanet, Dominique Drouin, Jacques Wepierre